Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Mastura I"'
Publikováno v:
Malaysian Family Physician, Vol 5, Iss 3, Pp 134-138 (2010)
Introduction: Hypertension is a common co-morbidity in diabetes mellitus (DM) that may lead to serious complications if notadequately controlled. Method: This is a descriptive study based on data from the Audit of Diabetes Control and Management (ADC
Externí odkaz:
https://doaj.org/article/c3fa589c5dec4127a6292275dd7df655
Autor:
MASTURA I
Publikováno v:
Malaysian Family Physician, Vol 5, Iss 1, Pp 53-56 (2010)
Non-communicable diseases (NCDs) represent among the most common and debilitating conditions seen in primary care. Patients’ care will often involves multiple providers and follow-up requires persistence by patients and clinicians alike, therefore
Externí odkaz:
https://doaj.org/article/31b725c8c55548b6a26ce36314a62b19
Autor:
MASTURA I
Publikováno v:
Malaysian Family Physician, Vol 3, Iss 2, Pp 113-116 (2008)
The Australian government had funded the National Primary Care Collaborative (NPCC) program with funding of $14.6 million over three years. One of the pilots project was the Arthritis and Musculoskeletal Quality Improvement Program (AMQuIP).The study
Externí odkaz:
https://doaj.org/article/26a6b2234b3345f1a30e196d937e43ed
Autor:
MASTURA I
Publikováno v:
Malaysian Family Physician, Vol 5, Iss 2, Pp 110-112 (2010)
Externí odkaz:
https://doaj.org/article/3f4aa76b85eb4bbd90173d95ef1d4676
Autor:
MASTURA I
Publikováno v:
Malaysian Family Physician, Vol 3, Iss 1, Pp 52-54 (2008)
Leadership in a huge and complex organisation like the Ministry of Health is important. The importance of leadership lies in the role it plays in defining the character, values and direction of an organization; and it’s relation to organizational p
Externí odkaz:
https://doaj.org/article/d8e0ab7976214bfb9e3584705bfe1c17
Autor:
MASTURA I
Publikováno v:
Malaysian Family Physician, Vol 3, Iss 3, Pp 168-169 (2008)
This article described the author’s reflection on conducting research in primary care. Certainly hand-on experience will give a better learning experience for a person to explore further in research and research training will help too. Conducting a
Externí odkaz:
https://doaj.org/article/d0792e7401324949b99455821702890c
Publikováno v:
Universum:Chemistry & biology. 96
Autor:
Ee Vien Low, Mohan Dass Pathmanathan, Yi Yang Ten, Suresh Kumar Chidambaram, Wee Ric Kim, Wei Jia Lee, Zhi Wei Teh, Maheshwara Rao Appannan, Mastura Ismail, Azah Abdul Samad, Kalaiarasu M. Peariasamy
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The effect of nirmatrelvir/ritonavir on preventing post-COVID condition (PCC) in the BA4, BA5, and XBB Omicron predominant periods is not well understood. The purpose of this study was to assess how nirmatrelvir/ritonavir treatmen
Externí odkaz:
https://doaj.org/article/bee5dbb338f14b44a6e178ea6248f6a9
Autor:
Kim Sui Wan, Foong Ming Moy, Muhammad Fadhli Mohd Yusoff, Feisul Mustapha, Mastura Ismail, Halizah Mat Rifin, Kishwen Kanna Yoga Ratnam, Hasimah Ismail, Kah Kian Chong, Noor Ani Ahmad, Noran Naqiah Hairi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Treatment intensification is essential to ensure guideline targets are attained in diabetes patients. The failure to intensify treatment when the targets are not achieved is therapeutic inertia. This study aimed to determine the proportions
Externí odkaz:
https://doaj.org/article/8514135b6fa44ba5a4be329b37a75f7b
Autor:
Ee Vien Low, Hoon Shien Teh, Nicholas Yee Liang Hing, Suresh Kumar Chidambaram, Mohan Dass Pathmanathan, Wee Ric Kim, Wei Jia Lee, Zhi Wei Teh, Maheshwara Rao Appannan, Shahanizan Mohd Zin, Faizah Muhamad Zin, Samha Bashirah Mohamed Amin, Mastura Ismail, Azah Abdul Samad, Kalaiarasu M. Peariasamy
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 2, Pp 299-308 (2024)
Abstract Background and objectives Nirmatrelvir/ritonavir was administered orally to manage mild to moderate symptoms of COVID-19 in adult patients. The objectives of this study were to (i) evaluate the cost-effectiveness of prescribing nirmatrelvir/
Externí odkaz:
https://doaj.org/article/31319d65f6fd40fd95597e28ebde83e5